SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 39 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,155,561 | $1,721,786 | 0.36% |
| Western Standard LLC | 46,117 | $68,714 | 0.06% |
| Deuterium Capital Management, LLC | 11,900 | $17,731 | 0.05% |
| Duquesne Family Office | 100,000 | $149,000 | 0.01% |
| Virtu Financial LLC | 26,060 | $39 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $168,221 | 0.00% |
| Ergoteles LLC | 34,340 | $51,167 | 0.00% |
| UBS Group AG | 1,097 | $1,635 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 31,076 | $46,303 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,570 | $17 | 0.00% |